Sphingolipid levels in MCF-7/Adr− and T47D breast tumor cell lines have been investigated following application of σ2R specific agonists in order to understand further the molecular mechanism by which σ2R ligands could cause their observed morphological and apoptotic effects in various cancer cell lines (103). The gene discussed is TMEM97; the disease is breast neoplasm.